Rostra Therapeutics attends Antimicrobial Resistance workshop hosted by CIFAR in Toronto, Canada

​

Our CEO, David Findlay, was delighted to be invited to attend a Canadian Institute for Advanced Research (CIFAR) meeting in Toronto earlier this year. Titled 'Catalyzing the Development of Fungicides and Antifungal Drugs: Challenges and Opportunities', the workshop addressed many key issues around the discovery and development of new antifungals at a time when there are limited fungicidal and therapeutic choices, many of which are becoming increasingly compromised by the increase in antimicrobial resistance (AMR).  Among the workshop attendees were academics, clinicians, public health, regulators, funders and industry representatives, leading to broad ranging discussions and the initiation of a set of recommendations to further support discovery and development in this critical area